L. Beltrán

发表

The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer

D. Berney, J. Shamash, C. Blank, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Prospective molecular and morphological assessment of testicular prepubertal-type teratomas in postpubertal men

D. Berney, A. Roe, J. Shamash, 2019, Modern Pathology.

A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK).

T. Powles, D. McLaren, S. Crabb, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Powles, T. et al. (2016) A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer

Š., R., D. McLaren, 2016 .

Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer.

G. Oades, M. Sullivan, Robert J. Jones, 2016, JAMA oncology.

Pathological risk factors for metastatic disease at presentation in testicular seminomas with focus on the recent pT changes in AJCC TNM 8th edition.

D. Berney, J. Shamash, C. Alifrangis, 2019, Human pathology.

Composite Hodgkin Lymphoma and Mantle Cell Lymphoma: Two Clonally Unrelated Tumors

Juan F. García, A. Sánchez-Aguilera, M. Piris, 2003, The American journal of surgical pathology.

The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis

D. Berney, Yong-jie Lu, Amar S. Ahmad, 2021, Cancers.

Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis.

D. Berney, Yong-jie Lu, D. Lin, 2010, Cancer research.

Chinese and Western prostate cancers show alternate pathogenetic pathways in association with ERG status.

D. Berney, Yong-jie Lu, D. Lin, 2012, American journal of cancer research.

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort

D M Berney, J Cuzick, J. Cuzick, 2015, British Journal of Cancer.

Ki-67 is an independent predictor of prostate cancer death in routine needle biopsy samples: proving utility for routine assessments

J. Cuzick, D. Berney, P. Scardino, 2019, Modern Pathology.

Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome

J. Cuzick, D. Berney, P. Scardino, 2016, British Journal of Cancer.

Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel MTOR-Activating Mutation.

C. Rodríguez-Antona, J. García-Donas, I. Durán, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

The Effect of VEGF-Targeted Therapy on Biomarker Expression in Sequential Tissue from Patients with Metastatic Clear Cell Renal Cancer

D. Berney, Yong-jie Lu, M. Gerlinger, 2013, Clinical Cancer Research.

Absolute Quantitation of DNA Methylation of 28 Candidate Genes in Prostate Cancer Using Pyrosequencing

J. Cuzick, D. Berney, Keqiang Wu, 2011, Disease markers.

Performing Cytoreductive Nephrectomy following Targeted Sunitinib Therapy for Metastatic Renal Cell Carcinoma: A Surgical Perspective

T. Powles, R. Nair, J. Peters, 2012, Urologia Internationalis.

Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy.

P. Nathan, D. McLaren, Janet E Brown, 2020, European urology focus.

761P Impact of the combination of durvalumab (MEDI4736) plus olaparib (AZD2281) administered prior to surgery in the molecular profile of resectable urothelial bladder cancer. NEODURVARIB trial

C. Rodríguez-Antona, J. García-Donas, A. Font, 2019, Annals of Oncology.

Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.

Yong-jie Lu, I. Tomlinson, B. Delage, 2014, Cancer Research.

Histopathologic False-positive Diagnoses of Prostate Cancer in the Age of Immunohistochemistry

J. Cuzick, D. Berney, Amar S. Ahmad, 2019, The American journal of surgical pathology.

The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.

D. Berney, J. Shamash, C. Blank, 2011, European urology.

The percentage of high‐grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death

J. Cuzick, D. Berney, P. Scardino, 2019, Histopathology.

Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively

J. Cuzick, D. Berney, P. Scardino, 2018, Oncotarget.

Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?

D. Berney, J. Shamash, C. Alifrangis, 2020, Modern Pathology.

High‐resolution genome‐wide copy‐number analysis suggests a monoclonal origin of multifocal prostate cancer

D. Berney, Yong-jie Lu, D. Lin, 2012, Genes, chromosomes & cancer.

Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma

M. Gerlinger, T. Powles, W. Prevoo, 2016, BMC Medicine.

Validation of an active surveillance threshold for the CCP score in conservatively managed men with localized prostate cancer.

J. Cuzick, D. Berney, P. Scardino, 2015 .

Measuring cancer burden in prostatic needle core biopsies: simplified assessments outperform complex measurements in assessing outcome: evidence to assist pathologist efficiency and minimize datasets

J. Cuzick, D. Berney, M. Varma, 2023, Histopathology.

The Effect of VEGF-Targeted Therapy on Biomarker Expression in Sequential Tissue from Patients with Metastatic Clear Cell Renal Cancer

D. Berney, M. Gerlinger, I. Kayani, 2013, Clinical Cancer Research.

Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.

I. Tomlinson, B. Delage, T. Crook, 2014, Cancer research.

Intravascular large B‐cell lymphoma presenting as a pituitary mass with bilateral adrenal enlargement and haemophagocytic lymphohistiocytosis

J. Shamash, W. Drake, A. Haroon, 2018, British journal of haematology.